Acro Biomedical (ACBM) Equity Average (2016 - 2025)
Acro Biomedical (ACBM) recorded quarterly Equity Average of -$409791.5 in Q4 2025, down 9.26% quarter-over-quarter from -$375069.5 in Q3 2025, and down 41.19% on a YoY basis from -$696824.1 in Q4 2024.
Acro Biomedical (ACBM) Equity Average (2016 - 2025) Analysis & Trends
Acro Biomedical's Equity Average history runs 10 years deep, the most recent figure standing at -$409791.5 for Q4 2025.
- In Q4 2025, Equity Average fell 41.19% year-over-year to -$409791.5; the TTM figure through Dec 2025 stood at -$409791.5 (down 41.19% YoY), while the FY2025 annual figure was -$340968.0, down 23.54% from the prior year.
- Equity Average was -$409791.5 for Q4 2025 at Acro Biomedical, down from -$375069.5 in the prior quarter.
- In the past five years, Equity Average ranged from a high of $657372.5 in Q1 2021 to a low of -$409791.5 in Q4 2025.
- Historically, Equity Average has averaged $145140.0 across 5 years, with a median of $212649.8 in 2023.
- The sharpest annual moves came in 2022 and 2024: Equity Average decreased 2.12% in 2022, then tumbled 661.67% in 2024.
- A 5-year view of Equity Average shows it stood at $605962.5 in 2021, then declined by 19.26% to $489267.0 in 2022, then sank by 150.75% to -$248313.5 in 2023, then slipped by 16.88% to -$290238.0 in 2024, then plunged by 41.19% to -$409791.5 in 2025.
- The last three Equity Average figures came in at -$409791.5 (Q4 2025), -$375069.5 (Q3 2025), and -$310713.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - | -16.34 Mn |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - | -14.44 Mn |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - | -11.95 Mn |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | -10.65 Mn |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - | -13.69 Mn |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | -13.60 Mn |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - | -28.22 Mn |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - | -8.00 Mn |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - | -29.87 Mn |
| 10 | Acro Biomedical | - | - | - | -409,791.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -409,791.50 |
| Sep 30, 2025 | -375,069.50 |
| Jun 30, 2025 | -310,713.00 |
| Mar 31, 2025 | -299,439.00 |
| Dec 31, 2024 | -290,238.00 |
| Sep 30, 2024 | -280,951.00 |
| Jun 30, 2024 | -271,855.00 |
| Mar 31, 2024 | -262,163.00 |
| Dec 31, 2023 | -248,313.50 |
| Sep 30, 2023 | 50,020.50 |
| Jun 30, 2023 | 375,279.00 |
| Mar 31, 2023 | 448,637.00 |
| Dec 31, 2022 | 489,267.00 |
| Sep 30, 2022 | 533,525.50 |
| Jun 30, 2022 | 609,053.00 |
| Mar 31, 2022 | 643,463.00 |
| Dec 31, 2021 | 605,962.50 |
| Sep 30, 2021 | 604,212.50 |
| Jun 30, 2021 | 634,542.00 |
| Mar 31, 2021 | 657,372.50 |